Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer (npj Breast Cancer
- Autori: Fabi A.; Carbognin L.; Botticelli A.; Paris I.; Fuso P.; Savastano M.C.; La Verde N.; Strina C.; Pedersini R.; Guarino S.; Curigliano G.; Criscitiello C.; Raffaele M.; Beano A.; Franco A.; Valerio M.R.; Verderame F.; Fontana A.; Haspinger E.R.; Caldara A.; Di Leone A.; Tortora G.; Giannarelli D.; Scambia G.
- Anno di pubblicazione: 2023
- Tipologia: Articolo in rivista
- OA Link: http://hdl.handle.net/10447/626673
Abstract
Correction to: npj Breast Cancer, published online 08 September 2023 In this article, the funding from Roche was inadvertently omitted. Additionally, in the Acknowledgements, the affiliation for Paola Tagliabue was incorrectly provided as ‘Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy’ and has been corrected to ‘Vimercate Hospital, ASST della Brianza, Vimercate, Italy’. The original article has been corrected.